NIRDs Dermatology Rare Disease Conference
November 13 to 15, 2026Orlando World Center Marriott, Orlando, Florida
The NIRDs Dermatology Rare Disease Conference is a national educational summit that brings together dermatologists, trainees, researchers, and industry partners to drive meaningful HCP engagement and deepen expertise in rare and immune-mediated dermatologic diseases.

Why Attend
A full program devoted to rare and immune-mediated skin disease as well as cancer. Immune blistering disease, cutaneous lupus, dermatomyositis, scleroderma, mast cell disorders, porphyrias, pustular psoriasis, alopecia areata, vitiligo, HS, and pediatric rare disease: conditions that rarely get dedicated time at general dermatology meetings.
Clinically applicable content
Sessions are structured around diagnostic evaluation, differential considerations, and evidence-based management approaches for low-prevalence conditions.
Cross-specialty perspective
Faculty from rheumatology, gastroenterology, oncology, immunology, and neurology present alongside dermatology, reflecting the multi-organ nature of these diseases and the realities of co-management.
Faculty access at a manageable scale
A focused meeting with a high faculty-to-attendee ratio allows direct discussion with faculty and peers rather than one-way lecture attendance.
A national peer community in rare dermatology
Academic and community dermatologists, NPs and PAs, and residents and fellows convened around a shared clinical focus.
Dedicated programming for trainees (NIRDs 360)
Residents and fellows attend alongside attendings, with education aimed at building rare disease competency early in training.
Specialized practice management tracks by profession
Ranging from clinical trials, working with industry, tools to enhance your practice, and professional development guidance.
An efficient format
Friday evening through Sunday morning, structured to limit time away from clinical practice.
What the meeting covers
Conditions that a general dermatology clinic sees rarely enough that the evidence never quite settles, taught by the clinicians who see them often.

- Pediatric psoriasis and psoriatic arthritis
- Alopecia areata
- Vitiligo
- Cutaneous lupus erythematosus
- Indolent and advanced systemic mastocytosis
- Hidradenitis suppurativa
- Generalized pustular psoriasis
- Locally advanced cutaneous squamous cell carcinoma
- Microcystic lymphatic and cutaneous venous malformations
- Rare manifestations of atopic dermatitis
- VEXAS syndrome
Who is in the room
300
Expected attendees
Total registration cap
200
MD and DO
Practicing dermatologists
50
PA and NP
Advanced practice clinicians
50
Residents and fellows
Through NIRDs 360
Support the meeting
Sponsorship and exhibit packages are scoped individually.